Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$12.2 million.

  • Wave Life Sciences' Net Cash Flow fell 10779.04% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$114.6 million, marking a year-over-year decrease of 16702.82%. This contributed to the annual value of $101.9 million for FY2024, which is 898.49% down from last year.
  • According to the latest figures from Q3 2025, Wave Life Sciences' Net Cash Flow is -$12.2 million, which was down 10779.04% from -$34.6 million recorded in Q2 2025.
  • Over the past 5 years, Wave Life Sciences' Net Cash Flow peaked at $156.9 million during Q3 2024, and registered a low of -$88.8 million during Q1 2022.
  • Its 5-year average for Net Cash Flow is $655000.0, with a median of -$19.3 million in 2024.
  • Its Net Cash Flow has fluctuated over the past 5 years, first surged by 141186.37% in 2022, then crashed by 20533.64% in 2025.
  • Quarter analysis of 5 years shows Wave Life Sciences' Net Cash Flow stood at $26.7 million in 2021, then crashed by 131.95% to -$8.5 million in 2022, then skyrocketed by 806.46% to $60.4 million in 2023, then tumbled by 114.5% to -$8.8 million in 2024, then crashed by 39.63% to -$12.2 million in 2025.
  • Its Net Cash Flow stands at -$12.2 million for Q3 2025, versus -$34.6 million for Q2 2025 and -$59.0 million for Q1 2025.